ReviewJournal of clinical medicine2022

New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies.

Daniel Sánchez-Tejerina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.